Multitargeted Virtual Screening and Molecular Simulation of Natural Product-like Compounds against GSK3β, NMDA-Receptor, and BACE-1 for the Management of Alzheimer’s Disease. Here, BACE1 is linked to early-onset autosomal dominant Alzheimer disease.